Search Results 741-750 of 19815 for Receptor

  1. Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome - Mayo Clinic

    This includes chimeric antigen receptor (CAR) T cell therapy and other immunotherapies. Inclusion Criteria - Patient to Proceed to HCT: - Karnofsky Index or ...

  2. Hematology - Clinical trials

    A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer. Rochester, Minn ...

  3. Cancer Clinical Trials - Medical Professionals

    ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

  4. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

    Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia. Molecular Therapy. 2020; doi:10.1016/j.

  5. FrαDcs Or Placebo For Patients With Advanced Stage Ovarian Cancer - Mayo Clinic

    About this study. The purpose of this study is to determine whether vaccination with folate receptor alpha dendritic cells (FRalphaDCs) given to patients ...

  6. Avapritinib (oral route) - Side effects & dosage - Mayo Clinic

    ... receptor alpha (PDGFRA) gene mutation. This medicine is also used to treat advanced systemic mastocytosis (AdvSM), including aggressive systemic ...

  7. Honorary Degree Recipients - Commencement - Mayo Clinic College of Medicine & Science

    This approach led to the isolation and functional analysis of the gene for the lymphocyte surface protein, CD4, the cellular receptor for the AIDS virus, HIV.

  8. Regenerative Medicine Minnesota awards 13 research grants for 2024 - Mayo Clinic News Network

    Optimized Chimeric Antigen Receptor T Cell Therapy for Colorectal Cancer ... Androgen Receptor Blockade to Augment Liver Regeneration. Rory Smoot, M.D. ...

  9. A Dose Escalation Study of Amivantamab in Participants with Advanced Non-Small Cell Lung Cancer - Mayo Clinic

    ... receptor [EGFR] tyrosine kinase inhibitor [TKI]; Cohort D and MET-2 ... For Part 2 only: Participants must also have disease with a previously diagnosed ...

  10. Clinical trials - Oncology (Medical)

    ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...